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Abstract 
We present a case of acute pancreatitis that happened as a complication of intragastric 
balloon insertion used for weight reduction in a young obese lady. Although many 
complications can happen with this type of procedure, this presentation is very rare and 
may not have been reported previously. The patient responded well to removal of the 
balloon since her pain resolved completely and her serum amylase normalized. She did 
not have any obvious cause of pancreatitis other than a significant radiologically proven 
compression of the pancreas by the balloon. 
 
Introduction 
Intragastric balloons are becoming an increasingly used modality for weight reduction 
in obese patients. Although endoscopic placement of an
 intragastric balloon 
(Garron-Edwards Gastric Bubble) was
 discontinued in 1987 because of a high 
complication rate, and similar finding in our department of frequent and serious 
complication and ineffectiveness regarding weight loss had led to stopping the use of 
balloon for weight reduction [1], more recent trials have shown better tolerability and a 
better safety profile of the procedure with the use of saline-filled Bioenteric Intragastric 
Balloon (BIB) System [2]. 
Many side effects have been reported after BIB insertion and they are mostly related to 
the pressure effect and rupture of the balloon. We present an interesting and rare 
complication of intragastric balloon used for treatment of obesity in one of our patients. 
Our department restarted insertion of BIB in June 2005 and till now over 135 balloons 
have been inserted. The tolerance rate is high (>90%) and that is mostly related to good 
information of the patients about the side effects of the procedure and to proper 
management of their symptoms after the procedure. Only one of these 135 patients had 
serious complications as reported below.  
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Case Presentation 
Our patient is a 31-year-old female nurse who was seen in the gastroenterology clinic for 
management of obesity after failing to reduce weight by diet and exercise. Her weight at presentation 
was 85 kg and her height was 162 cm with a BMI of 33.2. She was complaining of backache and knee 
pain which were attributed to osteoarthritic changes secondary to obesity. The patient had BIB inserted 
in the gastric fundus and filled with 600 ml of saline on 20th of November 2006. She tolerated the 
procedure initially and lost 16 kg over 75 days. She presented to the clinic ten weeks after BIB placement 
complaining of sudden acute severe epigastric pain and repeated vomiting. Examination revealed 
fullness in the epigastric area and tenderness; bowel sounds were present. 
Her initial laboratory tests showed normal full blood count, electrolytes and hepatic and renal 
profile. Her serum calcium was 2.2 mmol/l (normal 2.0–2.5), cholesterol was 5.5 mmol/l (normal <5.2) 
and triglyceride was 2.2 mmol/l (normal 0.45–1.7). Serum amylase was 502 U/l, which was more than 
three times the upper limit of normal (normal 0–100). 
The patient had emergency ultrasound of the abdomen which showed that the intragastric balloon 
was indenting the tail of the pancreas, but no peripancreatic fluid was noted. There were no gallstones 
and no evidence of biliary obstruction as the common bile duct diameter was 3 mm and no intrahepatic 
biliary dilatation was seen. A CT scan of the abdomen (fig. 1) was done and revealed a similar finding of 
a compressed body of the pancreas by distended stomach; the compression was exaggerated in the 
supine position. The patient has no history of alcohol consumption or use of medications known to 
precipitate pancreatitis. 
In view of the severity of symptoms, high amylase level and the ultrasound and CT scan findings, she 
was diagnosed as having acute pancreatitis attributed to the balloon. According to Ranson’s criteria her 
score at presentation was 0, and since there was no necrosis on CT scan it was graded as mild acute 
pancreatitis.  
Since the patient was symptomatic, she had an upper gastrointestinal endoscopy which showed a 
normal appearing esophagus, stomach and duodenum. During this procedure the intragastric balloon 
was removed from the gastric fundus on 6th of February 2007. The patient’s symptoms improved 
significantly and her amylase level came back to normal. The final diagnosis was mild acute pancreatitis 
caused by BIB insertion. 
Discussion 
BIB is a nonsurgical procedure that has been used in treating obesity and morbid 
obesity. It works by restriction of gastric intake. It is less invasive and cheaper than 
bariatric surgery but can only be left in the stomach for six months. The efficacy of this 
procedure is variable according to various clinical trials. While in one trial a 11.2 to 
12.8 kg loss of weight after 3 months and a 16.7 to 20.0 kg loss after 6 months of balloon 
treatment was achieved [2], others showed only 5.9 kg (7.5%) loss of starting body weight 
and 31% of excess weight [3] 6 months after balloon placement. 
Although endoscopic placement of BIB is considered safe and relatively easy compared 
to surgical treatment of obesity, patient tolerance remains one of the most important 
limitations for the use of this treatment modality. The majority of adverse effects of 
intragastric balloon are related to gastric distension and reduced gastric capacity, and the 
incidence of symptoms (nausea, vomiting, abdominal cramps) is directly related to 
balloon size [4, 5]. More serious adverse events have been reported including ulcers or 
erosions caused by the pressure on the gastric mucosa, tear as a result of improper 
placement of the balloon and migration of a leaking balloon causing obstruction of the 
gut. The incidence of mucosal injury is 4% and premature deflation of the balloon is 
required in 7–8%, although much higher rates were reported from an Asian group [3, 6]. 
Stomach perforation and severe esophagitis have also been reported [7–10].  
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In spite of the close relation of the stomach to the pancreas, we are not aware of any 
reported case of acute pancreatitis in relation to BIB insertion. Probably it is because of 
the site of the balloon which is usually located at the fundus of the stomach rather than 
the antrum. One case was reported of incomplete bowel obstruction and pancreatitis 
following dislodgement of the intragastric balloon [11]. 
Although our patient had her balloon placed in a good position, she still developed 
acute pancreatitis evident both clinically (epigastric pain and vomiting after a period of 
good tolerability of the balloon) and biochemically (hyperamylasemia) with radiological 
evidence of pressure effect on the pancreas. The improvement of her symptoms and 
return of amylase level to normal after BIB removal further adds to this diagnosis. 
Pancreatitis developed in this patient more than 2 months after insertion of the BIB; 
whether there was continuous pressure on the pancreas from the beginning or whether 
the balloon settled more in the fundus and caused pressure and irritation on the pancreas 
is difficult to determine at this stage. It is important to mention that the most common 
causes of acute pancreatitis, namely gallstones and alcohol, were excluded in this patient. 
Our previous observations have shown a low incidence of alcoholic pancreatitis in Saudi 
Arabia [12] that is probably related to alcohol prohibition in this country. 66% of 120 
acute pancreatitis cases presented to our hospital were biliary in origin and 6% of them 
were due to alcohol [13]. Many factors contribute to the development of acute 
alcohol-induced pancreatitis [14] and attacks can be recurrent with significant risk of 
chronic pancreatitis. 
The severity and prognosis of acute pancreatitis depend on particular prognostic 
systems or markers which include the calculation of positive and negative likelihood 
ratios derived from combination of sensitivity and specificity, and applying these 
parameters will be affected by pretest probability of the disease [15]. Luckily this patient 
had a mild attack of acute pancreatitis which responded well to removal of the causative 
agent and observation. In a severer form of acute pancreatitis many complications can 
occur, including pancreatic necrosis, infection, pseudocyst and retroperitoneal collection 
[16, 17]. 
We believe this is the first case report of acute pancreatitis following BIB insertion 
without displacement of the balloon. Reporting this case might increase physicians’ 
awareness of this complication. Since symptoms of pancreatitis can be misinterpreted as 
the effect of gastric distension by the balloon, this diagnosis can be missed in some 
patients, leading to more serious sequale and complications of pancreatitis. 
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Fig. 1. Abdominal CT scan showing intragastric compression of the tail of the pancreas. 
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